Abstract:Obesity-associated metabolic abnormalities comprise a cluster of conditions including dyslipidemia, insulin resistance, diabetes and cardiovascular diseases that has affected more than 650 million people all over the globe. Obesity results from the accumulation of white adipose tissues mainly due to the chronic imbalance of energy intake and energy expenditure. A variety of approaches to treat or prevent obesity, including lifestyle interventions, surgical weight loss procedures and pharmacological approaches to reduce energy intake and increase energy expenditure have failed to substantially decrease the prevalence of obesity. Brown adipose tissue (BAT), the primary source of thermogenesis in infants and small mammals may represent a promising therapeutic target to treat obesity by promoting energy expenditure through non-shivering thermogenesis mediated by mitochondrial uncoupling protein 1 (UCP1). Since the confirmation of functional BAT in adult humans by several groups, approximately a decade ago, and its association with a favorable metabolic phenotype, intense interest on the significance of BAT in adult human physiology and metabolic health has emerged within the scientific community to explore its therapeutic potential for the treatment of obesity and metabolic diseases. A substantially decreased BAT activity in individuals with obesity indicates a role for BAT in the setting of human obesity. On the other hand, BAT mass and its prevalence correlate with lower body mass index (BMI), decreased age and lower glucose levels, leading to a lower incidence of cardio-metabolic diseases. The increased cold exposure in adult humans with undetectable BAT was associated with decreased body fat mass and increased insulin sensitivity. A deeper understanding of the role of BAT in human metabolic health and its interrelationship with body fat distribution and deciphering proper strategies to increase energy expenditure, by either increasing functional BAT mass or inducing white adipose browning, holds the promise for possible therapeutic avenues for the treatment of obesity and associated metabolic disorders.

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues

Brown Adipose Tissue and Regulation of Human Body Weight

Weighing in on the role of brown adipose tissue for treatment of obesity

Nutritional Regulation of Human Brown Adipose Tissue

Brown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity

Brown Adipose Tissue Heterogeneity, Energy Metabolism, and Beyond

Econutrition, Brown And Beige Fat Tissue And Obesity

Brown Adipose Tissue: Activation and Metabolism in Humans

Mitochondrial Energy Metabolism in the Regulation of Thermogenic Brown Fats and Human Metabolic Diseases

[Brown Adipose Tissue in Human and Its Potential Physiological Significance].

Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis

Brown Adipose Tissue—A Translational Perspective

Brown adipose tissue is associated with cardiometabolic health

Energy dissipation in brown adipose tissue: From mice to men

An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications

Brown and Brite: The Fat Soldiers in the Anti-obesity Fight

Activating Brown Adipose Tissue as an Approach to Combat Obesity

Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity

Human thermogenic adipose tissue

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

Many Ways to Rome: Exercise, Cold Exposure and Diet—Do They All Affect BAT Activation and WAT Browning in the Same Manner?